Beyond Air, Inc. (NASDAQ: XAIR) announced that its chief executive officer, Steve Lisi, will step down effective March 27, 2026, and that Robert Goodman will assume the role of CEO effective March 26, 2026. Goodman, who previously served as the company’s chief commercial officer and a director, will lead the firm as it navigates a critical 12‑month execution window for its LungFit nitric‑oxide platform and the upcoming Gen II launch.
Goodman brings a decade of experience in commercial strategy and international market expansion. His background in driving sales growth and building distribution partnerships positions him to accelerate adoption of Beyond Air’s cylinder‑free nitric‑oxide technology, which has already secured FDA approval for its first‑generation LungFit PH system and is awaiting regulatory review for the smaller, transport‑ready Gen II version.
Beyond Air’s leadership change comes amid a challenging financial environment. The company recently cut its FY2025 revenue guidance from $15 million to $10 million after a breach of contract with Airgas, and it has been pursuing aggressive cost‑control and capital‑preservation measures to extend its cash runway. The appointment of a commercial‑focused CEO signals the board’s intent to sharpen sales execution and improve margin performance while the company continues to invest in product development and regulatory approvals.
"I am honored by the Board's trust and excited to lead Beyond Air into this next chapter," Goodman said. "Our technology delivers clear value, and we have a significant opportunity to expand adoption in the U.S. and international inhaled nitric oxide markets. I am fully committed to sharpening our commercial execution, strengthening customer partnerships, and scaling the company to achieve its substantial long‑term potential and deliver enhanced value for shareholders."
"On behalf of the entire Board, I want to thank Steve for his many years of dedicated service and visionary leadership. His contributions were critical in developing the LungFit system and positioning the Company for its next phase. As we focus on accelerating widespread market adoption of LungFit PH and scaling our commercial operations, the Board is confident that Bob Goodman's proven commercial and operational expertise in both the U.S. and international markets makes him the ideal leader to drive broader customer deployment and unlock Beyond Air's true potential."
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.